UBS Group’s Panacea Acquisition Corp. II Class A Ordinary Shares PANA Stock Holding History

UBS Group’s Portfolio PANA Stock Details PANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,567	Closed	-$16K	–	10381
2023 Q1	$16K	Buy	1,567 +424	+37%	+$4.29K	﹤0.01%	7256
2022 Q4	$11.5K	Buy	1,143 +500	+78%	+$4.95K	﹤0.01%	8395
2022 Q3	$6K	Hold	643	–	–	﹤0.01%	9126
2022 Q2	$6K	Hold	643	–	–	﹤0.01%	8790
2022 Q1	$6K	Sell	643 -225	-26%	-$2.18K	﹤0.01%	9044
2021 Q4	$8K	Hold	868	–	–	﹤0.01%	9094
2021 Q3	$8K	Sell	868 -2,209	-72%	-$21.8K	﹤0.01%	8255
2021 Q2	$31K	Buy	+3,077	New	+$30.8K	﹤0.01%	6911

UBS Group's PANA Position: Q2 2023 in Review

UBS Group sold out of Panacea Acquisition Corp. II Class A Ordinary Shares (PANA) in Q2 2023, closing a stake of 1,567 shares — an estimated $16K sold.

UBS Group first reported a position in PANA in Q2 2021 and held it in 8 quarters. The position peaked at $31K in Q2 2021. 0 funds tracked by Wall St. Rank hold PANA as of Q2 2023.

UBS Group reported no remaining Panacea Acquisition Corp. II Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
UBS Group sold 1,567 Panacea Acquisition Corp. II Class A Ordinary Shares shares in Q2 2023, an estimated $16K.
UBS Group first reported a position in Panacea Acquisition Corp. II Class A Ordinary Shares in Q2 2021 and held it in 8 quarters.
UBS Group's Panacea Acquisition Corp. II Class A Ordinary Shares position peaked at $31K in Q2 2021.
0 funds tracked by Wall St. Rank held Panacea Acquisition Corp. II Class A Ordinary Shares as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.